CymitQuimica logo

CAS 136209-43-3

:

{(3S,10S,13R,14R,17S)-3-hydroxy-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,5,6,7,10,11,12,13,17-dodecahydro-14H-cyclopenta[a]phenanthren-14-yl}acetic acid (non-preferred name)

Description:
The chemical substance with the name {(3S,10S,13R,14R,17S)-3-hydroxy-4,4,10,13-tetramethyl-17-[(2R)-6-methylheptan-2-yl]-1,2,3,4,5,6,7,10,11,12,13,17-dodecahydro-14H-cyclopenta[a]phenanthren-14-yl}acetic acid, identified by the CAS number 136209-43-3, is a complex organic compound characterized by its multi-ring structure and multiple stereocenters, which contribute to its specific three-dimensional configuration. This compound features a hydroxyl group and an acetic acid moiety, indicating potential for hydrogen bonding and reactivity typical of alcohols and carboxylic acids. The presence of multiple methyl groups suggests a degree of hydrophobicity, which may influence its solubility and interaction with biological systems. Its structural complexity and stereochemistry may also impart unique pharmacological properties, making it of interest in medicinal chemistry. The compound's specific interactions and potential applications would depend on its conformation and the functional groups present, which could affect its biological activity and therapeutic potential.
Formula:C31H50O3
InChI:InChI=1/C31H50O3/c1-20(2)9-8-10-21(3)22-14-18-31(19-27(33)34)24-11-12-25-28(4,5)26(32)15-16-29(25,6)23(24)13-17-30(22,31)7/h14,18,20-22,25-26,32H,8-13,15-17,19H2,1-7H3,(H,33,34)/t21-,22-,25?,26+,29-,30-,31-/m1/s1
Synonyms:
  • SK&F 104976
  • See more synonyms
Sort by

Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 2 products.
  • SK&F 104976

    CAS:
    SK&F 104976 is a 32-carboxylic acid derivative of lanosterol. It was found to be a potent lanosterol 14 alpha-demethylase (14 alpha DM) inhibitor.
    Formula:C31H50O3
    Purity:98%
    Color and Shape:Solid
    Molecular weight:470.73
  • Skf 104976

    Controlled Product
    CAS:
    <p>Skf 104976 is a synthetic retinoid that binds to the nuclear receptor, thereby activating gene transcription. It has been shown to inhibit the proliferation of cells in vitro and in vivo. Skf 104976 also inhibits the growth of cancer cells by inducing apoptosis and by inhibiting cell cycle progression. The synthetic pathway for skf 104976 is similar to that for all-trans retinoic acid (ATRA), but it differs from ATRA in that it does not have a hydroxyl group on carbon C-3 and C-4. In addition, Skf 104976 has synergistic effects when used with dihydrolanosterol, which inhibits liver cells from accumulating lipids. This drug may be useful as an anti-diabetic agent due to its ability to increase insulin sensitivity and stimulate glucose uptake in 3T3-L1 preadipocytes.</p>
    Purity:Min. 95%

    Ref: 3D-XS178050

    ne
    To inquire